$ZTS
ZOETIS INC.
XNYS•Health Care•Pharmaceutical Preparations
$71.75
▼-1.74%-$1.27
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ZTS down today? It is at $71.75 (-1.74%), and our scanner flagged it 94 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZTS spikes, and full due diligence on ZTS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ZTS 94 times in the last 30 days. Create a free account to track $ZTS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ZTS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ZTS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystZoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer, from an SEC filing. Read it →From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Damelio Frank A Director | Sold (automatic/other) | -7K | sold 31% | 15K | n/a | Aug 7, 26 |
Mccallister Michael B Director | Sold (automatic/other) | -1K | n/a | n/a | n/a | Jun 10, 26 |
Stetter Mark Director | Other | 2K | n/a | 2K | n/a | May 21, 26 |
Parent Louise M Director | Other | 12K | added 75% | 28K | n/a | May 20, 26 |
Bisaro Paul Director | Bought (open market) | +2K | added 7.7% | 28K | $152K at $75.88 | May 13, 26 |
Damelio Frank A Director | Bought (open market) | +7K | added 45% | 21K | $501K at $75.39 | May 13, 26 |
Mccallister Michael B Director | Bought (open market) | +3K | added 11% | 31K | $233K at $77.76 | May 11, 26 |
Esch Kevin Officer | Sold (automatic/other) | -75 | sold 11% | 578 | $9K at $114.97 | Apr 30, 26 |
Esch Kevin Officer | Other | 259 | added 66% | 653 | n/a | Apr 30, 26 |
Sarbaugh Keith Officer | Sold (automatic/other) | -524 | sold 14% | 3K | $62K at $118.21 | Mar 31, 26 |
Sarbaugh Keith Officer | Other | 2K | added 65% | 4K | n/a | Mar 31, 26 |
Norden Gregory Director | Sold (automatic/other) | -1K | n/a | n/a | n/a | Mar 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ZTS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ZTS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ZTS last traded at $71.75, down 1.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ZOETIS INC. (ZTS) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. ZTS currently has a dividend yield of about 2.97% ($2.12 per share per year). Dividend figures can change; this is not investment advice.
The ZTS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZTS 94 times in the last 30 days.
ZTS (ZOETIS INC.) trades on XNYS, with a market cap of about $29.50B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZTS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ZTS discussion
Sign in to ask a question or join the discussion.